Shire recently joined the European Federation of Pharmaceutical Industries and Associations (EFPIA). This means we can play a bigger role in shaping European healthcare policy with patients in mind as well as defending against cuts to public healthcare budgets. We will also benefit from EFPIA’s market and policy intelligence, meetings and influence in Brussels and across the region. This will help us better understand and influence policy and regulations at the European Union and country levels, and support the Federation’s focus on growth, competitiveness and trade.
We’ve become a more mature company, and with that comes added responsibility,” says Joff Masukawa, Vice President, Global Government Relations. “It was time for us to join. Although we’re not as big as many other members, our membership has been very well received.”
EFPIA is a federation of 39 leading pharmaceutical companies and 33 national associations representing the pharmaceutical industry in Europe.